Addus HomeCare Corporation $ADUS Shares Sold by Natixis Advisors LLC

Natixis Advisors LLC cut its position in Addus HomeCare Corporation (NASDAQ:ADUS) by 29.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 32,946 shares of the company’s stock after selling 13,780 shares during the quarter. Natixis Advisors LLC owned approximately 0.18% of Addus HomeCare worth $3,538,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. boosted its position in shares of Addus HomeCare by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company’s stock valued at $140,531,000 after purchasing an additional 10,501 shares during the period. Capital Research Global Investors lifted its position in Addus HomeCare by 9.0% during the 3rd quarter. Capital Research Global Investors now owns 1,201,560 shares of the company’s stock worth $141,772,000 after acquiring an additional 99,262 shares during the period. Wasatch Advisors LP lifted its position in Addus HomeCare by 0.8% during the 3rd quarter. Wasatch Advisors LP now owns 936,243 shares of the company’s stock worth $110,467,000 after acquiring an additional 7,089 shares during the period. State Street Corp lifted its position in Addus HomeCare by 1.3% during the 2nd quarter. State Street Corp now owns 693,368 shares of the company’s stock worth $79,869,000 after acquiring an additional 8,925 shares during the period. Finally, Dimensional Fund Advisors LP lifted its position in Addus HomeCare by 1.2% during the 3rd quarter. Dimensional Fund Advisors LP now owns 667,256 shares of the company’s stock worth $78,729,000 after acquiring an additional 7,884 shares during the period. 95.35% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ADUS has been the subject of a number of recent research reports. Stephens decreased their price objective on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a research report on Wednesday, February 25th. Barclays decreased their price objective on Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating for the company in a research report on Friday, May 15th. KeyCorp reaffirmed an “overweight” rating on shares of Addus HomeCare in a research report on Wednesday, February 25th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research report on Wednesday, February 25th. Finally, Citizens Jmp reaffirmed a “market outperform” rating and set a $142.00 price objective on shares of Addus HomeCare in a research report on Monday, May 18th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $131.00.

Addus HomeCare Stock Up 2.2%

ADUS opened at $92.70 on Wednesday. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.83 and a quick ratio of 1.83. The business has a 50 day simple moving average of $93.78 and a 200-day simple moving average of $103.64. The stock has a market capitalization of $1.73 billion, a P/E ratio of 17.13, a P/E/G ratio of 1.24 and a beta of 0.89. Addus HomeCare Corporation has a 12 month low of $87.95 and a 12 month high of $124.43.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, May 4th. The company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.52 by $0.10. The business had revenue of $363.50 million during the quarter, compared to analysts’ expectations of $366.41 million. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The company’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same period last year, the firm earned $1.42 EPS. On average, equities analysts anticipate that Addus HomeCare Corporation will post 6.24 earnings per share for the current fiscal year.

Addus HomeCare Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.